APA (7th ed.) Citation

Z, M., M, A. Z., A, I., & M, A. (2025). Cardiotoxicity Profiles of Osimertinib Compared with Other EGFR Tyrosine Kinase Inhibitors: A Real-World Comparative Incidence Analysis. Targeted oncology, 20(6), 1015. https://doi.org/10.1007/s11523-025-01180-2

Chicago Style (17th ed.) Citation

Z, Muhanna, Al Zyoud M, Issa A, and Awidi M. "Cardiotoxicity Profiles of Osimertinib Compared with Other EGFR Tyrosine Kinase Inhibitors: A Real-World Comparative Incidence Analysis." Targeted Oncology 20, no. 6 (2025): 1015. https://doi.org/10.1007/s11523-025-01180-2.

MLA (9th ed.) Citation

Z, Muhanna, et al. "Cardiotoxicity Profiles of Osimertinib Compared with Other EGFR Tyrosine Kinase Inhibitors: A Real-World Comparative Incidence Analysis." Targeted Oncology, vol. 20, no. 6, 2025, p. 1015, https://doi.org/10.1007/s11523-025-01180-2.